Sodium Aluminum Phosphate vs Acesulfame Potassium: which is worse?

What is Sodium Aluminum Phosphate?

Sodium aluminum phosphate (SALP) is a leavening acid and food additive used in baked goods, particularly self-rising flour and baking powder. It provides a slow, sustained leavening action during baking. SALP is also used as an emulsifying salt in processed cheese products.

What is Acesulfame Potassium?

Acesulfame potassium (Ace-K) is a calorie-free synthetic sweetener approximately 200 times sweeter than sucrose. It contains a potassium atom bonded to an oxathiazinone dioxide ring structure. It is heat-stable and non-metabolized, passing through the body unchanged. Often blended with sucralose or aspartame to mask bitter aftertaste.

Documented risks

Sodium Aluminum Phosphate: The primary health concern with SALP is aluminum exposure. Dietary aluminum intake has been studied in relation to neurotoxicity, and there is ongoing scientific debate about whether chronic dietary aluminum exposure contributes to Alzheimer's disease risk. EFSA's 2008 review of dietary aluminum exposure concluded that the tolerable weekly intake (TWI) was being exceeded by some European populations based on total dietary aluminum sources, raising concern. A 2011 EFSA risk assessment noted that certain high-aluminum sources (including baked goods from SALP-containing leavening agents) contributed meaningfully to total dietary aluminum. The WHO has set a PTWI (provisional tolerable weekly intake) of 2 mg/kg body weight/week for total aluminum. However, the causal link between dietary aluminum from food-grade SALP and Alzheimer's disease has not been definitively established in human studies.

Acesulfame Potassium: The safety database for Ace-K is considered less comprehensive than that for other sweeteners. Critics have argued that the original FDA approval studies from the 1970s-1980s were insufficient in quality and length to definitively establish long-term safety. The Center for Science in the Public Interest (CSPI) has petitioned for additional testing. Two rat studies found statistically significant increases in lung tumors (in male rats) and mammary tumors at high doses. Regulatory agencies have argued these doses far exceeded typical human exposure and attributed the tumor findings to other factors. However, the question of whether Ace-K's approval studies meet modern standards has been raised by independent researchers. A 2021 study in Cell found that Ace-K and other non-nutritive sweeteners altered gut microbiome composition and affected glucose tolerance in some human participants. Ace-K specifically was associated with changes in gut bacteria that correlated with glycemic effects. Neurological concerns: some animal studies suggest Ace-K may affect brain neurotransmitter systems. A 2013 study in PLoS ONE found that Ace-K consumption in pregnant mice altered offspring postnatal taste preference and increased weight gain, suggesting potential transgenerational effects. These findings were at doses exceeding typical human intake. Endocrine disruption potential has been raised in some in vitro studies, but comprehensive human data are lacking.